Vericel stem cell therapy cuts heart failure death, hospitalization: study
(Reuters) - A stem cell therapy developed by Vericel Corp helped reduce deaths and hospitalizations in advanced heart failure patients, according to data from a midstage study, potentially providing a treatment that could delay the need for heart transplants.
Aucun commentaire:
Enregistrer un commentaire